Company confirmed from its website. How we verify
Synapse Biomedical researches, develops and commercializes neurostimulator devices intended to go beyond current methods of treatment. Its NeuRx DPS® diaphragm pacing system, FDA cleared, is designed to reduce reliance on mechanical ventilators in patients with spinal cord injuries. The company also offers the TransAeris® system, designed for the prevention and treatment of ventilator induced diaphragm dysfunction, and Synchrony®, aimed at stroke recovery. Its facility holds ISO 13485 certification.
Description based on the company's website.
Products manufactured
Product illustrations, until the company adds its own photos.
Tritonis verification index
How the index is calculatedLittle verifiable information so far. The company can complete its listing for free.
The factor-by-factor breakdown, the comparison of your suppliers and alerts are reserved for buyer accounts. See the details and compare
Request a quote
Describe what you need: your request is sent to Synapse Biomedical, who can reply to you directly.
Other suppliers: Medical and dental instruments
-
Aesculap, Inc.Main product at 0% Canadian duty
See all suppliers of this product
Spotted an error on this listing?
Report it: we review every report, usually within two business days. No account is needed.
Source: Connecticut Secretary of the State, Business Registry (public domain).
Recently viewed





